(S (NP-SBJ (NP (ADJP (NN NF-kappa) (JJ B-dependent)) (NN induction)) (PP (IN of) (NP (DT the) (NN NF-kappa) (NN B) (NN p50) (NN subunit) (NN gene) (NN promoter)))) (VP (VBZ underlies) (NP (NP (NN self-perpetuation)) (PP (IN of) (NP (JJ human) (NN immunodeficiency) (NN virus) (NN transcription))) (PP (IN in) (NP (JJ monocytic) (NNS cells))))) (. .))
(S (NP-SBJ-23 (NP (DT The) (JJ molecular) (NNS mechanisms)) (VP (VBG underlying) (NP (NP (DT the) (JJ sustained) (JJ nuclear) (NN translocation)) (PP (IN of) (NP (NN NF-kappa) (NN B))) (VP (VBN observed) (NP (-NONE- *)) (PP (IN in) (NP (NP (NN U937) (JJ monocytic) (NNS cells)) (VP (ADVP (RB chronically)) (VP (VBN infected) (NP (-NONE- *)) (PP (IN with) (NP (NP (JJ human) (NN immunodeficiency) (NN virus)) (PRN (-LRB- -LRB-) (NP (NN HIV)) (-RRB- -RRB-)))))))))))) (VP (VBD were) (VP (VBN studied) (NP (-NONE- *-23)))) (. .))
(S (NP-SBJ-24 (NP (DT The) (NN activity)) (PP (IN of) (NP (DT the) (NN promoter))) (VP (VBG regulating) (NP (NP (DT the) (NN synthesis)) (PP (IN of) (NP (NP (DT the) (NN p105) (NN precursor)) (PP (IN of) (NP (DT the) (NN NF-kappa) (NN B) (NN p50) (NN subunit)))))))) (VP (VBD was) (VP (VBN enhanced) (NP (-NONE- *-24)) (PP (IN in) (NP (DT these) (NNS cells))))) (. .))
(S (NP-SBJ (NP (NNS Deletions)) (PP (IN in) (NP (DT this) (NN promoter)))) (VP (VBD indicated) (SBAR (IN that) (S (NP-SBJ-25 (DT this) (NN upregulation)) (VP (VBD was) (VP (VBN mediated) (NP (-NONE- *-25)) (PP (IN through) (NP (NP-COOD (NP (DT the) (ADJP (NP (NN NF-kappa) (NN B-)) (ADJP (-NONE- *?*))) (NP (-NONE- *RNR*-101))) (CONJP (CC but) (RB not)) (NP (DT the) (JJ AP-1-binding) (NP (-NONE- *RNR*-101)))) (NP-101 (NN motif)))) (, ,) (PP (IN by) (NP (ADJP (FW bona) (FW fide)) (NN (p65 p50)) (NNS heterodimers)))))))) (. .))
(S (NP-SBJ (NP (NN Analysis)) (PP (IN of) (NP (JJ cytosolic) (NNS extracts)))) (VP (VBD indicated) (SBAR (IN that) (S (NP-SBJ-26 (NN NF-kappa) (NN B) (NNS levels)) (VP (VBD were) (VP (VBN increased) (NP (-NONE- *-26)) (PP (IN in) (NP (JJ HIV-infected) (NNS cells)))))))) (. .))
(S (PP (IN In) (NN contrast) (TO to) (NP (NP (DT the) (JJ transient) (NN NF-kappa) (NN B) (NN activation)) (VP (VBN induced) (NP (-NONE- *)) (PP (IN by) (NP-LGS (NN phorbol) (NN ester)))))) (, ,) (NP-SBJ-102 (NP (DT the) (JJ permanent) (NN NF-kappa) (NN B) (NN translocation)) (VP (VBN induced) (NP (-NONE- *)) (PP (IN by) (NP-LGS (NN HIV) (NN infection))))) (VP (VBD was) (RB not) (ADJP-PRD (JJ dependent) (PP (IN on) (NP (NN PKC) (NNS isoenzymes) (NP-COOD (NP (NN alpha)) (CC and) (NP (NN beta)))))) (SBAR (IN as) (S (NP-SBJ-27 (-NONE- *-102)) (VP (VBN shown) (NP (-NONE- *-27)) (PP (IN by) (NP-LGS (NP (DT the) (NN use)) (PP (IN of) (NP (NP (DT a) (JJ specific) (NN inhibitor)) (PRN (-LRB- -LRB-) (NP (NN GF) (NN 109203X)) (-RRB- -RRB-)))))))))) (. .))
(S (NP-SBJ (DT These) (NNS observations)) (VP (VBP indicate) (SBAR (IN that) (S (PP-TMP (IN during) (NP (NP (JJ chronic) (NN HIV) (NN infection)) (PP (IN of) (NP (NN U937) (NNS cells))))) (, ,) (NP-SBJ (JJ continuous) (NN NF-kappa) (NN B) (PRN (-LRB- -LRB-) (NP (NN (p65 p50))) (-RRB- -RRB-)) (NN translocation)) (VP (VBZ results) (PP (IN in) (NP (NP (NN p105) (NN promoter) (NN upregulation)) (PP (IN with) (NP (NP (JJ subsequent) (JJ cytosolic) (NN NF-kappa) (NN B) (NN accumulation)) (, ,) (ADJP (JJ ready) (PP (IN for) (NP (JJ further) (NN translocation)))))))))))) (. .))
(S (NP-SBJ (DT This) (JJ HIV-mediated) (NN mechanism)) (VP (VBZ results) (PP (IN in) (NP (NP (DT a) (JJ self-perpetuating) (NN loop)) (PP (IN of) (NP (NN NF-kappa) (NN B) (NN production)))))) (. .))
